A Study of OV101 in Individuals With Angelman Syndrome (AS)

Clinical trial NCT04106557 · COMPLETED

Trial details

NCT number: NCT04106557
Sponsor: Healx AI
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Disease or Condition Being Studied: Angelman Syndrome (AS)

Start date: 2019-09-09
Primary completion: 2020-11-02
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.